Zantac Lawsuit

If you or a loved one have been diagnosed with cancer after using Zantac for at least several months, you may be entitled to substantial compensation. Fill out the form below and we will contact you.

You may have heard in the news that Zantac (ranitidine) has been linked to cancer. Lawsuits against Zantac manufacturers allege the drug contains a cancer-causing chemical called N-Nitrosodimethylamine (NDMA).

The law firm of Levy & Partners, PLLC, and Mac Legal, P.A. represent individuals from all over the United States in personal injury Zantac lawsuits. We intend to hold the drug makers accountable for allegedly concealing the Zantac cancer link and putting profit before people.

What is Zantac?

Chemically known as ranitidine hydrochloride, Zantac (ranitidine) belongs to a class of drugs called histamine H2-receptor antagonists (or H2 blockers), which decrease the amount of acid produced by the stomach.

Zantac is a very popular antacid medication that has been on the market since the early 1980s. Zantac is available over the counter (Zantac OTC) and by prescription. People commonly use Zantac for acid reflux, heartburn, and a host of other stomach, throat, and gastrointestinal issues. Others use Zantac for allergies to supplement their treatment regimen.

Zantac dosage varies between 75 and 150 mg tablets, though some patients take a once daily Zantac 300 mg dosage.

Since the 1980s, numerous studies have demonstrated a link between the NDMA in Zantac and cancer. Mounting evidence also allegedly shows that Defendant drug manufacturers, the big pharma companies that make Zantac (ranitidine hydrochloride), concealed the Zantac cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux, and other issues. The Defendant big pharma companies made billions in profit from Zantac throughout the decades.

Ranitidine in the News

The U.S. Food and Drug Administration (FDA) announced on September 13, 2019 that it is investigating Zantac cancer risks after testing of Zantac 150 tablets found the commonly-used heartburn medication contains NDMA at levels up to 3,000 times greater than the FDA’s daily intake limit. The Zantac cancer lawyers at  Levy & Partners, PLLC believe there is no safe level of NDMA.

With countless people now stricken with cancer after taking Zantac, many are turning to the courts and filing a Zantac lawsuit to hold Sanofi and Boehringer Ingelheim and numerous other manufacturers and distributors of Zantac accountable for their reckless disregard for human health and willingness to put profit over people.

On April 1, 2020, the FDA issued an immediate market withdrawal request of all Zantac (ranitidine) products after determining that NDMA in “some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…”

Prior to the FDA market withdrawal of ranitidine, numerous manufacturers issued generic Zantac recalls on their own, including Apotex, Sandoz (Novartis), and GlaxoSmithKline (GSK) after Valisure, an online pharmacy that batch tests the medications it sells, and Emery Pharma, a contract laboratory, found unacceptably high levels of NDMA in ranitidine during testing. Both filed citizen’s petitions with the FDA, urging the agency to suspend sales and issue a Zantac recall. Some versions of Zantac were also recalled in Canada and Europe.

Join the Zantac Lawsuit

If you took Zantac and developed cancer, it is in your best interest to speak with an experienced personal injury attorney about filing a Zantac lawsuit. Attorneys from the law firm of  Levy & Partners, PLLC, and Mac Legal, P.A. have vast experience holding big corporations accountable for their misdeeds.

Zantac Recall

In response to the September 2019 FDA announcement, retailers like CVS and Walgreens pulled Zantac and Zantac over-the-counter generics from their shelves, citing the link between Zantac NDMA and cancer. In statements, both pharmacy companies noted that consumers who purchased the drugs could get Zantac refunds. Generic drug makers like GlaxoSmithKline (GSK), Sandoz, and Apotex have also recalled its ranitidine hydrochloride products.

In October of 2019, Sanofi announced a Zantac recall of its own in the United States and Canada, and the U.K. unit of Teva Pharmaceuticals, the largest generic drug maker in the world, recalled batches of ranitidine.

At least 22 countries have either banned, halted shipping of, or recalled ranitidine hcl. Four other countries have issued warnings and/or launched their own investigations, according to the news media.

In 2018, several companies issued recalls for blood pressure medications that contained levels of NDMA that exceeded FDA limits. However, the levels of NDMA found in these products paled in comparison to that of Zantac.

Zantac Side Effects

The link between Zantac and cancer goes back decades. Our firm represents people from across the country with the following Zantac side effects:

• Bladder cancer

• Brain cancer

• Breast cancer

• Esophageal/nasal/throat cancer

• Intestinal cancer

• Kidney cancer

• Liver cancer

• Lung cancer (for non-smokers)

• Ovarian cancer

• Pancreatic cancer

• Prostate cancer

• Stomach cancer

• Testicular cancer

• Thyroid cancer

• Uterine cancer

Other ranitidine Zantac side effects include headaches, abdominal discomfort, nausea and vomiting.

Common Zantac Brands | Products That Contain Ranitidine

Below are some of the most common Zantac brands and generic ranitidine brand names:

• Zantac 150 Tablets

• Zantac 150 Maximum Strength

• Zantac 150 Maximum Strength Cool Mint

• Zantac 75 Tablets

• Wal-Zan 150

• Wal-Zan 75

• Heartburn Relief (ranitidine)

• Acid Reducer (ranitidine)

• Acid Control (ranitidine)

You Need a Zantac Attorney with a Proven Track Record of Success

Our trial lawyers know how to win big cases against big companies. If you developed cancer after taking Zantac, call 954-727-8570 today for a free, no-obligation Zantac lawsuit evaluation.